Following a public consultation, the Medicines and Health Products Regulatory Agency (MHRA) is making Nuromol, a medicine containing 200 mg of ibuprofen and 500 mg of paracetamol per tablet available without the need to travel to pharmacy.
Dr Sarah Branch, Director of Drug Vigilance and Risk Management at MHRA, said:
This reclassification on the general sales list will help people manage their pain where paracetamol or ibuprofen alone has not provided adequate pain relief.
Greater availability of medicines and improving patient access and choice remain a priority for health. The MHRA is committed to improving access to medicines for personal care where it is safe.
Nuromol is used for the temporary relief of mild to moderate pain associated with migraine, headache, back pain, period pain, toothache, rheumatic and muscle pain, non-severe arthritis pain, cold and flu symptoms, sore throat and fever when paracetamol or ibuprofen alone have not provided adequate pain relief.
While most people can take paracetamol, ibuprofen is not suitable for everyone, and it is also important that people do not exceed the recommended dose of 1 or 2 tablets no more than 3 times a day. Patients are also advised not to take more than one medicine containing paracetamol at the same time.
The MHRA’s decision to reclassify this product follows a review by the Commission for Medicinal Products for Human Use (CHM) and public consultation. The CHM advises ministers on the safety, efficacy and quality of medicines.
The response to the consultation is available here